Targeted therapy doubles progression-free survival in rare bile duct cancer
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid…
Experts call for rapid improvements in diagnosis, treatment of bile duct cancer
The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in…